Optimal decision rules for HTA under uncertainty: A wider, dynamic perspective

Health Economics (United Kingdom)

Volumn 22, Issue 12, 2013, Pages 1507-1514

  Forster, Martin ^a   Pertile, Paolo ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

dynamic programming; economic evaluation; real options

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG ELUTING STENT; ECONOMIC EVALUATION; HEALTH CARE POLICY; MEDICAL RESEARCH; PRIORITY JOURNAL; RESOURCE ALLOCATION; UNCERTAINTY;

DYNAMIC PROGRAMMING; ECONOMIC EVALUATION; REAL OPTIONS;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DRUG-ELUTING STENTS; HUMANS; MODELS, THEORETICAL; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TECHNOLOGY TRANSFER; UNCERTAINTY;

EID: 84887228627     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.2893     Document Type: Article

References (21)

1. Chalkidou K, Lord J, Fischer A, Littlejohns P,. 2008. Evidence-based decision making: when should we wait for more information? Health Affairs 270 (6): 1642-1653.
2. Chernoff H,. 1965a. Sequential tests for the mean of a normal distribution III. Annals of Mathematical Statistics 36: 28-54.
3. Chernoff H,. 1965b. Sequential tests for the mean of a normal distribution IV. Annals of Mathematical Statistics 36: 55-68.
4. Chick SE, Gans N,. 2009. Economic analysis of simulation selection problems. Management Science 550 (3): 421-437.
5. Claxton K,. 1999. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 180 (3): 341-364.
6. Claxton K, Thompson KM,. 2001. A dynamic programming approach to the efficient design of clinical trials. Journal of Health Economics 200 (5): 797-822.
7. Conti S, Claxton K,. 2009. Dimensions of design space: a decision-theoretic approach to optimal research design. Medical Decision Making 29: 643-660.
8. Davis JC, Marra CA, Robertson MC, Khan KM, Najafzadeh M, Ashe MC, Liu-Ambrose T,. 2011. Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporosis International 220 (5): 1355-1366.
9. Dixit A, Pindyck R,. 1994. Investment under Uncertainty (1st edn). Princeton University Press: Princeton, New Jersey.
10. Eckermann S, Willan AR,. 2008. The option value of delay in health technology assessment. Medical Decision Making 280 (3): 300-305.
11. Griffin S, Claxton K, Palmer SJ, Sculpher MJ,. 2011. Dangerous omissions: the consequences of ignoring decision uncertainty. Health Economics 200 (2): 212-224.
12. Longworth L, Bojke L, Tosh J, Sculpher M,. 2009. MRC-NICE scoping project: identifying the National Institute for Health and Clinical Excellence's methodological research policies and an initial set of priorities. Centre for Health Economics Research Paper 51, University of York.
13. McKenna C, Chalabi Z, Epstein D, Claxton K,. 2010. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. Journal of Health Economics 29: 170-181.
14. Meltzer DO, Smith PC,. 2011. Theoretical issues relevant to the economic evaluation of health technologies. In Handbook of Health Economics. Elsevier; 433-469.
15. National Institute for Health and Clinical Excellence. 2008. Drug-eluting stents for the treatment of coronary artery disease. Part review of NICE technology appraisal guide 71.
16. Palmer S, Smith PC,. 2000. Incorporating option values into the economic evaluation of health care technologies. Journal of Health Economics 19: 755-766.
17. Pertile P, Forster M, La Torre D,. 2010. Optimal sequential sampling rules for the economic evaluation of health technologies. Department of Economics and Related Studies Discussion Paper, University of York 2010/24.
18. Roberts K, Weitzman ML,. 1981. Funding criteria for research, development and exploration projects. Econometrica 490 (5): 1261-1288.
19. Velde SJ, Veerman JL, TakNI, Bosmans JE, Klepp K, Brug J,. 2011. Modeling the long term health outcomes and cost-effectiveness of two interventions promoting fruit and vegetable intake among schoolchildren. Economics and Human Biology 90 (1): 14-22.
20. Whitehurst DGT, Bryan S, Hay EM, Thomas E, Young J, Foster NE,. 2011. Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee. Physical Therapy 910 (5): 630-641.
21. Younis T, Skedgel C,. 2011. Adjuvant trastuzumab for breast cancer uncertainties in clinical and economic evidence following early stopping of the HERA trial. PharmacoEconomics 290 (5): 361-365.